Engineering of the epigenome: synthetic biology to define functional causality and develop innovative therapies (Q51553005)

From Wikidata

Jump to navigation Jump to search

scientific article published on 21 January 2016

edit

Language	Label	Description	Also known as
English	Engineering of the epigenome: synthetic biology to define functional causality and develop innovative therapies	scientific article published on 21 January 2016

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26791441

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/26791441

editorial

0 references

title

Engineering of the epigenome: synthetic biology to define functional causality and develop innovative therapies (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26791441

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/26791441

main subject

synthetic biology

1 reference

based on heuristic

inferred from title

author name string

Jörg Tost

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26791441

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/26791441

publication date

21 January 2016

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26791441

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/26791441

published in

Epigenomics

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26791441

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/26791441

volume

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26791441

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/26791441

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26791441

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/26791441

page(s)

153-156

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26791441

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/26791441

cites work

Epigenetic Editing: targeted rewriting of epigenetic marks to modulate expression of selected target genes

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FEPI.15.112

retrieved

21 January 2018

Genome engineering with targetable nucleases

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FEPI.15.112

retrieved

21 January 2018

Synthetic epigenetics-towards intelligent control of epigenetic states and cell identity

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FEPI.15.112

retrieved

21 January 2018

Strategies for precision modulation of gene expression by epigenome editing: an overview

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FEPI.15.112

retrieved

21 January 2018

Induced DNA demethylation by targeting Ten-Eleven Translocation 2 to the human ICAM-1 promoter

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FEPI.15.112

retrieved

21 January 2018

Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FEPI.15.112

retrieved

21 January 2018

Targeted methylation and gene silencing of VEGF-A in human cells by using a designed Dnmt3a-Dnmt3L single-chain fusion protein with increased DNA methylation activity

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FEPI.15.112

retrieved

21 January 2018

Targeted methylation of the epithelial cell adhesion molecule (EpCAM) promoter to silence its expression in ovarian cancer cells

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FEPI.15.112

retrieved

21 January 2018

Towards sustained silencing of HER2/neu in cancer by epigenetic editing

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FEPI.15.112

retrieved

21 January 2018

TALE-mediated epigenetic suppression of CDKN2A increases replication in human fibroblasts

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FEPI.15.112

retrieved

21 January 2018

Locus-specific editing of histone modifications at endogenous enhancers

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FEPI.15.112

retrieved

21 January 2018

Chromosomal contact permits transcription between coregulated genes

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FEPI.15.112

retrieved

21 January 2018

Development and applications of CRISPR-Cas9 for genome engineering

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FEPI.15.112

retrieved

21 January 2018

In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FEPI.15.112

retrieved

21 January 2018

CTCF establishes discrete functional chromatin domains at the Hox clusters during differentiation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FEPI.15.112

retrieved

21 January 2018

Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FEPI.15.112

retrieved

21 January 2018

Functional annotation of native enhancers with a Cas9-histone demethylase fusion.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FEPI.15.112

retrieved

21 January 2018

CRISPR-Cas9: a new and promising player in gene therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FEPI.15.112

retrieved

21 January 2018

Inhibition of Super-Enhancer Activity in Autoinflammatory Site-Derived T Cells Reduces Disease-Associated Gene Expression

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FEPI.15.112

retrieved

21 January 2018

Synthesizing AND gate genetic circuits based on CRISPR-Cas9 for identification of bladder cancer cells

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2217%2FEPI.15.112

retrieved

21 January 2018

Identifiers

DOI

10.2217/EPI.15.112

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26791441

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/26791441

PubMed publication ID

26791441

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26791441

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/26791441

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51553005&oldid=2276836179"